Adial Pharmaceuticals Warrant
ADILW
ADILW was delisted on the 27th of July, 2023.
2 hedge funds and large institutions have $6K invested in Adial Pharmaceuticals Warrant in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
25% less capital invested
Capital invested by funds: $8K → $6K (-$2K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$1.64K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Ameriprise
Minneapolis,
Minnesota
| $4K | – | – | – |
|
|
WAM
2
Wolverine Asset Management
Chicago,
Illinois
| $2K | +$1.64K | +4,240 | +130% |
|
ADILW Hedge Fund Activity: Q2 2022 in Review
2 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Adial Pharmaceuticals Warrant (ADILW) for Q2 2022, worth a combined $6K — down 25% from $8K a quarter earlier.
Fund positioning in ADILW was balanced in Q2 2022: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Wolverine Asset Management, adding an estimated $1.64K.
- 2 institutional investors held Adial Pharmaceuticals Warrant (ADILW) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $6K of Adial Pharmaceuticals Warrant stock for Q2 2022, down 25% quarter-over-quarter.
- 0 funds opened new Adial Pharmaceuticals Warrant positions in Q2 2022 and 0 closed out.
- The largest Adial Pharmaceuticals Warrant buyer in Q2 2022 was Wolverine Asset Management, an estimated $1.64K added.
Based on aggregated 13F filings for Q2 2022.